We analyzed the downstream outputs from the GPR143 signaling pathway that may relate to the racial or pigmentation bias of the disease (illustrated in Figure 5), and then we tested whether supplementation with the ligand for GPR143 treats AMD. The gene discussed is GPR143; the disease is age-related macular degeneration.